Nodenza Venture Partners

Trellis Bioscience LLC is a biotechnology company focused on discovering and developing human antibody therapeutics for infectious diseases and oncology. The company utilizes its proprietary CellSpot technology platform to identify and extract rare, naturally optimized antibodies from healthy human donor blood cells. This enables the development of therapeutic monoclonal antibodies targeting various infectious diseases and cancer immune checkpoints. Trellis aims to offer alternatives for patients facing challenges with conventional protein therapeutics, particularly in cases where the immune system may attack these treatments. Founded in 1998, Trellis Bioscience is headquartered in Redwood City, California.

Insight Surgery, through its subsidiary 3D LifePrints UK Ltd, specializes in medical 3D printing solutions tailored for the healthcare sector. The company collaborates closely with clinicians to create personalized synthetic replicas of patients' organs, enhancing surgical planning and patient communication. Its offerings include a wide range of products such as 3D printed pharmaceuticals, prosthetics, implants, medical devices, and bioprinted tissues. Additionally, 3D LifePrints produces anatomical models derived from patient data, which are utilized for training, simulation, and procedural preparation. The organization is also involved in the printing of facial burn masks, soft-tissue facial prostheses, and dental products, and it develops medical modeling software solutions. Founded in 2013 and based in Liverpool, the company primarily serves the National Health Service, private hospitals, universities, and medical training centers, striving to improve complex treatment outcomes in areas such as pediatrics, oncology, and orthopedics.